GLENMARK PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss
The total revenue of GLENMARK for the last quarter is 34.34 B INR, and it's 5.84% higher compared to the previous quarter. The net income of Q2 24 is 3.54 B INR.